According to Latest Research, the global market for Anthracyclines should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Anthracyclines market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Anthracyclines market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Oral segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Leukemia has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Anthracyclines include AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Lilly, Amgen Inc, GSK plc, Johnson & Johnson Services, Inc, Pfizer Inc and Meiji Holdings Co., Ltd, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Anthracycline is a type of antibiotic that is extracted from numerous types of Streptomyces bacteria. They are used for the treatment of various types of cancer. It damages the DNA of cancer cells and stop its function. This can be done either by intercalating into the base pairs in the DNA minor grooves or by causing free radical damage of the ribose in the DNA. Daunorubicin, doxorubicin, and epirubicin are some of the top examples of anthracyclines.
This report aims to provide a comprehensive study of the global market for Anthracyclines. Report Highlights:
(1) Global Anthracyclines market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Anthracyclines market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Anthracyclines market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Anthracyclines segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Anthracyclines segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Anthracyclines, capacity, production and trends.
(7) Anthracyclines industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Oral
Parenteral
Market segment by application, can be divided into
Leukemia
Hodgkin Lymphoma
Bladder Cancer
Breast Cancer
Other
Market segment by players, this report covers
AstraZeneca
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Lilly
Amgen Inc
GSK plc
Johnson & Johnson Services, Inc
Pfizer Inc
Meiji Holdings Co., Ltd
MicroBiopharm Japan Co., Ltd
Synbias Pharma
Hikma Pharmaceuticals PLC
Cumberland Pharmaceuticals Inc
Cadila Pharmaceuticals
Cipla Inc
1 Market Overview
1.1 Anthracyclines Definition
1.2 Global Anthracyclines Market Size and Forecast
1.2.1 By Revenue, Global Anthracyclines Market Size, 2018-2029
1.2.2 By Sales Volume, Global Anthracyclines Market Size, 2018-2029
1.2.3 Global Anthracyclines Price Trend, 2018-2029
1.3 China Anthracyclines Market Size and Forecast
1.3.1 By Revenue, China Anthracyclines Market Size, 2018-2029
1.3.2 By Sales Volume, China Anthracyclines Market Size, 2018-2029
1.3.3 China Anthracyclines Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Anthracyclines Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Anthracyclines Share in Global Market, 2018-2029
1.4.3 Anthracyclines Market Size: China VS Global, 2018-2029
1.5 Anthracyclines Market Dynamics
1.5.1 Anthracyclines Market Drivers
1.5.2 Anthracyclines Market Restraints
1.5.3 Anthracyclines Industry Trends
1.5.4 Anthracyclines Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Anthracyclines Revenue by Company, 2018-2023
2.2 Global Anthracyclines Sales Volume by Company, 2018-2023
2.3 Global Anthracyclines Price by Company, 2018-2023
2.4 Global Anthracyclines Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Anthracyclines Concentration Ratio
2.6 Global Anthracyclines Mergers & Acquisitions, Expansion Plans
2.7 Global Anthracyclines Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Anthracyclines Revenue by Company, 2018-2023
3.2 China Anthracyclines Sales Volume by Company, 2018-2023
3.3 China Anthracyclines Anthracyclines Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Anthracyclines Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Anthracyclines Domestic VS Export
3.6 China Market, Anthracyclines Import & Export
3.6.1 China Market, Anthracyclines Import & Export, 2018-2029
3.6.2 China Anthracyclines Import & Export Trends
3.6.3 Main Sources of China Anthracyclines Import
3.6.4 Export Destination of China Anthracyclines
4 Anthracyclines Production by Region
4.1 Global Anthracyclines Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Anthracyclines Manufacturers
4.3 Global Major Manufacturers, Anthracyclines Capacity Expansion and Future Plans
4.4 Global Anthracyclines Capacity by Region
4.5 Global Anthracyclines Production by Region
4.5.1 Global Anthracyclines Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Anthracyclines Production by Region, 2018-2023
4.5.3 Global Anthracyclines Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Anthracyclines Industry Chain
5.2 Anthracyclines Upstream Analysis
5.2.1 Anthracyclines Core Raw Materials
5.2.2 Main Manufacturers of Anthracyclines Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Anthracyclines Production Mode
5.6 Anthracyclines Procurement Model
5.7 Anthracyclines Industry Sales Model and Sales Channels
5.7.1 Anthracyclines Sales Model
5.7.2 Anthracyclines Typical Distributors
6 Sights by Type
6.1 Anthracyclines Classification
6.1.1 Oral
6.1.2 Parenteral
6.2 By Type, Global Anthracyclines Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Anthracyclines Revenue, 2018-2029
6.4 By Type, Global Anthracyclines Sales Volume, 2018-2029
6.5 By Type, Global Anthracyclines Price, 2018-2029
7 Sights by Application
7.1 Anthracyclines Segment by Application
7.1.1 Leukemia
7.1.2 Hodgkin Lymphoma
7.1.3 Bladder Cancer
7.1.4 Breast Cancer
7.1.5 Other
7.2 By Application, Global Anthracyclines Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Anthracyclines Revenue, 2018-2029
7.4 By Application, Global Anthracyclines Sales Volume, 2018-2029
7.5 By Application, Global Anthracyclines Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Anthracyclines Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Anthracyclines Revenue, 2018-2029
8.3 By Region, Global Anthracyclines Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Anthracyclines Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Anthracyclines Market Size Market Share
8.5 Europe
8.5.1 Europe Anthracyclines Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Anthracyclines Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Anthracyclines Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Anthracyclines Market Size Market Share
8.7 South America
8.7.1 South America Anthracyclines Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Anthracyclines Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Anthracyclines Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Anthracyclines Revenue, 2018-2029
9.3 By Country, Global Anthracyclines Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Anthracyclines Market Size, 2018-2029
9.4.2 By Company, U.S. Anthracyclines Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Anthracyclines Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Anthracyclines Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Anthracyclines Market Size, 2018-2029
9.5.2 By Company, Europe Anthracyclines Sales Volume Market Share, 2022
9.5.3 By Type, Europe Anthracyclines Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Anthracyclines Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Anthracyclines Market Size, 2018-2029
9.6.2 By Company, China Anthracyclines Sales Volume Market Share, 2022
9.6.3 By Type, China Anthracyclines Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Anthracyclines Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Anthracyclines Market Size, 2018-2029
9.7.2 By Company, Japan Anthracyclines Sales Volume Market Share, 2022
9.7.3 By Type, Japan Anthracyclines Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Anthracyclines Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Anthracyclines Market Size, 2018-2029
9.8.2 By Company, South Korea Anthracyclines Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Anthracyclines Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Anthracyclines Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Anthracyclines Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Anthracyclines Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Anthracyclines Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Anthracyclines Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Anthracyclines Market Size, 2018-2029
9.10.2 By Company, India Anthracyclines Sales Volume Market Share, 2022
9.10.3 By Type, India Anthracyclines Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Anthracyclines Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Anthracyclines Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Anthracyclines Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Anthracyclines Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Anthracyclines Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.1.2 AstraZeneca Anthracyclines Models, Specifications and Application
10.1.3 AstraZeneca Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AstraZeneca Company Profile and Main Business
10.1.5 AstraZeneca Recent Developments
10.2 Sun Pharmaceutical Industries Ltd
10.2.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.2.2 Sun Pharmaceutical Industries Ltd Anthracyclines Models, Specifications and Application
10.2.3 Sun Pharmaceutical Industries Ltd Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.2.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.3 Merck & Co., Inc
10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.3.2 Merck & Co., Inc Anthracyclines Models, Specifications and Application
10.3.3 Merck & Co., Inc Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck & Co., Inc Company Profile and Main Business
10.3.5 Merck & Co., Inc Recent Developments
10.4 Lilly
10.4.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.4.2 Lilly Anthracyclines Models, Specifications and Application
10.4.3 Lilly Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Lilly Company Profile and Main Business
10.4.5 Lilly Recent Developments
10.5 Amgen Inc
10.5.1 Amgen Inc Company Information, Head Office, Market Area and Industry Position
10.5.2 Amgen Inc Anthracyclines Models, Specifications and Application
10.5.3 Amgen Inc Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Amgen Inc Company Profile and Main Business
10.5.5 Amgen Inc Recent Developments
10.6 GSK plc
10.6.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.6.2 GSK plc Anthracyclines Models, Specifications and Application
10.6.3 GSK plc Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GSK plc Company Profile and Main Business
10.6.5 GSK plc Recent Developments
10.7 Johnson & Johnson Services, Inc
10.7.1 Johnson & Johnson Services, Inc Company Information, Head Office, Market Area and Industry Position
10.7.2 Johnson & Johnson Services, Inc Anthracyclines Models, Specifications and Application
10.7.3 Johnson & Johnson Services, Inc Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Johnson & Johnson Services, Inc Company Profile and Main Business
10.7.5 Johnson & Johnson Services, Inc Recent Developments
10.8 Pfizer Inc
10.8.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.8.2 Pfizer Inc Anthracyclines Models, Specifications and Application
10.8.3 Pfizer Inc Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Pfizer Inc Company Profile and Main Business
10.8.5 Pfizer Inc Recent Developments
10.9 Meiji Holdings Co., Ltd
10.9.1 Meiji Holdings Co., Ltd Company Information, Head Office, Market Area and Industry Position
10.9.2 Meiji Holdings Co., Ltd Anthracyclines Models, Specifications and Application
10.9.3 Meiji Holdings Co., Ltd Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Meiji Holdings Co., Ltd Company Profile and Main Business
10.9.5 Meiji Holdings Co., Ltd Recent Developments
10.10 MicroBiopharm Japan Co., Ltd
10.10.1 MicroBiopharm Japan Co., Ltd Company Information, Head Office, Market Area and Industry Position
10.10.2 MicroBiopharm Japan Co., Ltd Anthracyclines Models, Specifications and Application
10.10.3 MicroBiopharm Japan Co., Ltd Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 MicroBiopharm Japan Co., Ltd Company Profile and Main Business
10.10.5 MicroBiopharm Japan Co., Ltd Recent Developments
10.11 Synbias Pharma
10.11.1 Synbias Pharma Company Information, Head Office, Market Area and Industry Position
10.11.2 Synbias Pharma Anthracyclines Models, Specifications and Application
10.11.3 Synbias Pharma Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Synbias Pharma Company Profile and Main Business
10.11.5 Synbias Pharma Recent Developments
10.12 Hikma Pharmaceuticals PLC
10.12.1 Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
10.12.2 Hikma Pharmaceuticals PLC Anthracyclines Models, Specifications and Application
10.12.3 Hikma Pharmaceuticals PLC Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Hikma Pharmaceuticals PLC Company Profile and Main Business
10.12.5 Hikma Pharmaceuticals PLC Recent Developments
10.13 Cumberland Pharmaceuticals Inc
10.13.1 Cumberland Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position
10.13.2 Cumberland Pharmaceuticals Inc Anthracyclines Models, Specifications and Application
10.13.3 Cumberland Pharmaceuticals Inc Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Cumberland Pharmaceuticals Inc Company Profile and Main Business
10.13.5 Cumberland Pharmaceuticals Inc Recent Developments
10.14 Cadila Pharmaceuticals
10.14.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.14.2 Cadila Pharmaceuticals Anthracyclines Models, Specifications and Application
10.14.3 Cadila Pharmaceuticals Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Cadila Pharmaceuticals Company Profile and Main Business
10.14.5 Cadila Pharmaceuticals Recent Developments
10.15 Cipla Inc
10.15.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.15.2 Cipla Inc Anthracyclines Models, Specifications and Application
10.15.3 Cipla Inc Anthracyclines Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Cipla Inc Company Profile and Main Business
10.15.5 Cipla Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Anthracyclines Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Anthracyclines Market Restraints
Table 3. Anthracyclines Market Trends
Table 4. Anthracyclines Industry Policy
Table 5. Global Anthracyclines Revenue by Company, 2018-2023, US$ million
Table 6. Global Anthracyclines Revenue Market Share by Company, 2018-2023
Table 7. Global Anthracyclines Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Anthracyclines Sales Volume Market Share by Company, 2018-2023
Table 9. Global Anthracyclines Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Anthracyclines Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Anthracyclines Mergers & Acquisitions, Expansion Plans
Table 12. Global Anthracyclines Manufacturers Product Type
Table 13. China Anthracyclines Revenue by Company, 2018-2023, US$ million
Table 14. China Anthracyclines Revenue Market Share by Company, 2018-2023
Table 15. China Anthracyclines Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Anthracyclines Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Anthracyclines Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Anthracyclines Import & Export Trends
Table 19. Main Sources of China Anthracyclines Import
Table 20. Export Destination of China Anthracyclines
Table 21. Global Headquarters and Manufacturing Base of Anthracyclines Manufacturers
Table 22. Global Major Manufacturers, Anthracyclines Capacity Expansion and Future Plans
Table 23. Global Anthracyclines Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Anthracyclines Production by Region, 2018-2023, (K Units)
Table 25. Global Anthracyclines Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Anthracyclines Upstream (Raw Materials)
Table 27. Global Anthracyclines Typical Customers
Table 28. Anthracyclines Typical Distributors
Table 29. By Type, Global Anthracyclines Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Anthracyclines Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Anthracyclines Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Anthracyclines Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Anthracyclines Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Anthracyclines Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Anthracyclines Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Anthracyclines Revenue Market Share, 2018-2029
Table 37. By Country, Global Anthracyclines Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Anthracyclines Sales Volume Market Share, 2018-2029
Table 39. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 40. AstraZeneca Anthracyclines Models, Specifications and Application
Table 41. AstraZeneca Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. AstraZeneca Company Profile and Main Business
Table 43. AstraZeneca Recent Developments
Table 44. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 45. Sun Pharmaceutical Industries Ltd Anthracyclines Models, Specifications and Application
Table 46. Sun Pharmaceutical Industries Ltd Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 48. Sun Pharmaceutical Industries Ltd Recent Developments
Table 49. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 50. Merck & Co., Inc Anthracyclines Models, Specifications and Application
Table 51. Merck & Co., Inc Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Merck & Co., Inc Company Profile and Main Business
Table 53. Merck & Co., Inc Recent Developments
Table 54. Lilly Company Information, Head Office, Market Area and Industry Position
Table 55. Lilly Anthracyclines Models, Specifications and Application
Table 56. Lilly Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Lilly Company Profile and Main Business
Table 58. Lilly Recent Developments
Table 59. Amgen Inc Company Information, Head Office, Market Area and Industry Position
Table 60. Amgen Inc Anthracyclines Models, Specifications and Application
Table 61. Amgen Inc Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Amgen Inc Company Profile and Main Business
Table 63. Amgen Inc Recent Developments
Table 64. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 65. GSK plc Anthracyclines Models, Specifications and Application
Table 66. GSK plc Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. GSK plc Company Profile and Main Business
Table 68. GSK plc Recent Developments
Table 69. Johnson & Johnson Services, Inc Company Information, Head Office, Market Area and Industry Position
Table 70. Johnson & Johnson Services, Inc Anthracyclines Models, Specifications and Application
Table 71. Johnson & Johnson Services, Inc Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Johnson & Johnson Services, Inc Company Profile and Main Business
Table 73. Johnson & Johnson Services, Inc Recent Developments
Table 74. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 75. Pfizer Inc Anthracyclines Models, Specifications and Application
Table 76. Pfizer Inc Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Pfizer Inc Company Profile and Main Business
Table 78. Pfizer Inc Recent Developments
Table 79. Meiji Holdings Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 80. Meiji Holdings Co., Ltd Anthracyclines Models, Specifications and Application
Table 81. Meiji Holdings Co., Ltd Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Meiji Holdings Co., Ltd Company Profile and Main Business
Table 83. Meiji Holdings Co., Ltd Recent Developments
Table 84. MicroBiopharm Japan Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 85. MicroBiopharm Japan Co., Ltd Anthracyclines Models, Specifications and Application
Table 86. MicroBiopharm Japan Co., Ltd Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. MicroBiopharm Japan Co., Ltd Company Profile and Main Business
Table 88. MicroBiopharm Japan Co., Ltd Recent Developments
Table 89. Synbias Pharma Company Information, Head Office, Market Area and Industry Position
Table 90. Synbias Pharma Anthracyclines Models, Specifications and Application
Table 91. Synbias Pharma Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Synbias Pharma Company Profile and Main Business
Table 93. Synbias Pharma Recent Developments
Table 94. Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
Table 95. Hikma Pharmaceuticals PLC Anthracyclines Models, Specifications and Application
Table 96. Hikma Pharmaceuticals PLC Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Hikma Pharmaceuticals PLC Company Profile and Main Business
Table 98. Hikma Pharmaceuticals PLC Recent Developments
Table 99. Cumberland Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position
Table 100. Cumberland Pharmaceuticals Inc Anthracyclines Models, Specifications and Application
Table 101. Cumberland Pharmaceuticals Inc Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Cumberland Pharmaceuticals Inc Company Profile and Main Business
Table 103. Cumberland Pharmaceuticals Inc Recent Developments
Table 104. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 105. Cadila Pharmaceuticals Anthracyclines Models, Specifications and Application
Table 106. Cadila Pharmaceuticals Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Cadila Pharmaceuticals Company Profile and Main Business
Table 108. Cadila Pharmaceuticals Recent Developments
Table 109. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 110. Cipla Inc Anthracyclines Models, Specifications and Application
Table 111. Cipla Inc Anthracyclines Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Cipla Inc Company Profile and Main Business
Table 113. Cipla Inc Recent Developments
List of Figure
Figure 1. Anthracyclines Picture
Figure 2. By Revenue, Global Anthracyclines Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Anthracyclines Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Anthracyclines Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Anthracyclines Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Anthracyclines Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Anthracyclines Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Anthracyclines Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Anthracyclines Share of Global Market, 2018-2029
Figure 10. Global Anthracyclines Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Anthracyclines Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Anthracyclines Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Anthracyclines Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Anthracyclines Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Anthracyclines Domestic VS Export, 2022
Figure 16. Global Anthracyclines Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Anthracyclines Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Anthracyclines Production Market Share & Forecast by Region, 2018-2029
Figure 19. Anthracyclines Industry Chain
Figure 20. Anthracyclines Procurement Model
Figure 21. Anthracyclines Sales Model
Figure 22. Anthracyclines Sales Channels, Direct Sales and Distribution
Figure 23. Oral
Figure 24. Parenteral
Figure 25. By Type, Global Anthracyclines Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Anthracyclines Revenue Market Share, 2018-2029
Figure 27. By Type, Global Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Anthracyclines Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Anthracyclines Price, 2018-2029, (US$/Unit)
Figure 30. Leukemia
Figure 31. Hodgkin Lymphoma
Figure 32. Bladder Cancer
Figure 33. Breast Cancer
Figure 34. Other
Figure 35. By Application, Global Anthracyclines Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Anthracyclines Revenue Market Share, 2018-2029
Figure 37. By Application, Global Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Anthracyclines Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Anthracyclines Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Anthracyclines Revenue Market Share, 2018-2029
Figure 41. By Region, Global Anthracyclines Sales Volume Market Share, 2018-2029
Figure 42. North America Anthracyclines Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Anthracyclines Revenue Market Share, 2022
Figure 44. Europe Anthracyclines Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Anthracyclines Revenue Market Share, 2022
Figure 46. Asia Pacific Anthracyclines Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Anthracyclines Revenue Market Share, 2022
Figure 48. South America Anthracyclines Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Anthracyclines Revenue Market Share, 2022
Figure 50. Middle East & Africa Anthracyclines Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Anthracyclines Market Share, 2022
Figure 53. By Type, U.S. Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Anthracyclines Market Share, 2022
Figure 57. By Type, Europe Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 59. China Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Anthracyclines Market Share, 2022
Figure 61. By Type, China Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Anthracyclines Market Share, 2022
Figure 65. By Type, Japan Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Anthracyclines Market Share, 2022
Figure 69. By Type, South Korea Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Anthracyclines Market Share, 2022
Figure 73. By Type, Southeast Asia Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 75. India Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Anthracyclines Market Share, 2022
Figure 77. By Type, India Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Anthracyclines Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Anthracyclines Market Share, 2022
Figure 81. By Type, Middle East & Asia Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Anthracyclines Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|